Ambien (Zolpidem) Cost in Maine: Pricing, Insurance, and Savings in 2026

At a glance
- Generic zolpidem average cash price in Maine / approximately $15 per month (2026)
- Brand-name Ambien manufacturer list price / $120 per month
- Maine Medicaid coverage status / covered with prior authorization required
- Telehealth prescribing in Maine / permitted for zolpidem
- Compounded zolpidem via 503A pharmacy / legal in Maine
- Standard dosing / 5 mg or 10 mg oral tablet, once at bedtime
- DEA schedule / Schedule IV controlled substance
- FDA-approved indication / short-term treatment of insomnia
- Typical treatment duration per guidelines / 2 to 4 weeks for initial course
What Does Zolpidem Actually Cost in Maine Right Now?
The average cash price for a 30-count supply of generic zolpidem 10 mg in Maine sits near $15 in 2026. That is one of the lowest generic drug prices on the pharmacy shelf. Brand-name Ambien, manufactured by Sanofi, carries a list price of about $120 per month, though very few patients pay that figure out of pocket because generic alternatives are widely stocked.
Maine's pharmacy market follows national trends for zolpidem pricing. After Ambien lost patent exclusivity in 2007, generic competition drove retail costs down sharply. The FDA's Orange Book lists more than a dozen approved generic manufacturers of zolpidem tartrate immediate-release tablets [1]. Price variation between Maine pharmacies does exist. A Walgreens in Portland may charge $12 while an independent pharmacy in Bangor quotes $19 for the same 30-tablet supply. Calling ahead or using a price-comparison tool can save a few dollars each month.
Zolpidem extended-release (Ambien CR) costs more than the immediate-release formulation. Generic zolpidem ER typically runs $25 to $40 per month at Maine pharmacies, depending on dose and retailer. The brand-name Ambien CR list price exceeds $400 per month. The clinical evidence supporting extended-release over immediate-release for most patients is limited. A 2010 polysomnography study by Krystal et al. (N=212) demonstrated that zolpidem ER 12.5 mg improved sleep maintenance measures compared to placebo, but head-to-head data against the cheaper immediate-release formulation remain sparse [2].
Maine Medicaid Coverage for Zolpidem
Maine Medicaid covers zolpidem, but a prior authorization (PA) is required before the state program will pay for it. The PA process exists because Medicaid preferred drug lists generally favor non-benzodiazepine hypnotics with step-therapy protocols.
To obtain PA approval, prescribers typically must document that the patient has tried and failed at least one first-line behavioral intervention or alternative medication. Sleep hygiene counseling is often the initial recommended step per American Academy of Sleep Medicine (AASM) guidelines, which position cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment [3]. Maine's Medicaid program, known as MaineCare, processes most PA requests within 24 to 72 hours. Urgent requests can receive same-day review.
Patients enrolled in MaineCare pay no copay for generic zolpidem once PA is approved. The program covers both immediate-release and extended-release formulations, though the ER version may require additional clinical justification. Dual-eligible beneficiaries (those with both Medicare Part D and MaineCare) should check their Part D formulary first, as Medicare typically serves as the primary payer for outpatient prescriptions.
Insurance Coverage Beyond Medicaid
Private insurance plans sold in Maine through the Health Insurance Marketplace and employer-sponsored plans almost universally cover generic zolpidem. The drug sits on Tier 1 (preferred generic) of most commercial formularies.
Typical copays range from $0 to $15 per month. Anthem Blue Cross, Aetna, and Harvard Pilgrim Health Care, three of the largest insurers operating in Maine, all list generic zolpidem on their 2026 formularies without prior authorization for the immediate-release tablet [4]. Brand-name Ambien, by contrast, lands on Tier 3 or is excluded entirely on many plans. Patients who specifically want brand-name Ambien should expect to pay $50 to $80 after insurance, depending on their plan's cost-sharing structure.
Medicare Part D plans in Maine also cover generic zolpidem. The 2026 Part D redesign under the Inflation Reduction Act caps total annual out-of-pocket drug spending at $2,000 for Medicare beneficiaries [5]. For a drug as inexpensive as generic zolpidem, this cap is unlikely to matter. A full year of zolpidem at $15 per month totals $180, well below the threshold.
Quantity limits are common across insurers. Most plans restrict zolpidem to 30 tablets per 30-day fill, consistent with once-nightly dosing. The FDA label recommends the lowest effective dose: 5 mg for women and either 5 mg or 10 mg for men, a sex-based dosing distinction the agency implemented in 2013 after pharmacokinetic data showed women metabolize zolpidem more slowly [6].
Is Compounded Zolpidem Legal in Maine?
Yes. Compounded zolpidem is legal in Maine when prepared by a licensed 503A compounding pharmacy operating under a valid prescription for an individual patient. Federal law under the Drug Quality and Security Act (DQSA) of 2013 establishes the framework for 503A compounding, and Maine state pharmacy regulations align with this federal structure [7].
A compounding pharmacy might prepare zolpidem in a non-standard dosage form. Sublingual troches, flavored suspensions, or low-dose capsules (such as 1 mg or 2.5 mg) are examples. These formulations can be useful for patients who cannot swallow tablets or who need a dose not commercially available. Compounded formulations are not FDA-approved, and they do not undergo the same bioequivalence testing as manufactured generics. The AASM and FDA both caution that compounded drugs should be used only when a commercially available product cannot meet the patient's needs [3].
Pricing for compounded zolpidem varies by pharmacy. Some 503A pharmacies in Maine offer compounded zolpidem at minimal markup when the active ingredient cost is low, as zolpidem tartrate powder is inexpensive in bulk. Patients should verify that their compounding pharmacy holds current Maine Board of Pharmacy licensure.
Telehealth Prescribing of Zolpidem in Maine
Maine permits telehealth prescribing of zolpidem. The state enacted telehealth parity legislation (Maine Title 24-A, Section 4316) that requires insurers to cover telehealth visits at the same rate as in-person encounters [8]. Prescribers can evaluate insomnia patients via synchronous video and, when clinically appropriate, prescribe zolpidem.
There is a federal layer to consider. Zolpidem is a Schedule IV controlled substance under the Controlled Substances Act. The DEA's pandemic-era telehealth flexibilities allowed initial controlled-substance prescriptions via telehealth without an in-person visit. As of 2025, the DEA finalized rules extending telehealth prescribing authority for Schedule III through V substances under specific conditions, including a requirement for an audio-visual evaluation [9]. Maine providers who follow these federal rules can legally initiate zolpidem prescriptions through telehealth.
Several telehealth platforms serve Maine residents for insomnia management. Patients should confirm that any telehealth provider they use is licensed in Maine and has a valid DEA registration for the state. The prescription can be sent electronically to any Maine pharmacy, including mail-order pharmacies that deliver statewide.
How to Get the Cheapest Zolpidem in Maine
Generic zolpidem is already one of the least expensive prescription medications available. Still, several strategies can lower the cost further.
Pharmacy discount cards. GoodRx, RxSaver, and similar platforms often show zolpidem 10 mg (30 tablets) priced between $4 and $10 at Maine pharmacies when using a discount coupon. These cards are free and can be used by uninsured or underinsured patients. They do not count toward insurance deductibles.
Manufacturer savings programs. Sanofi has periodically offered savings cards for brand-name Ambien, though these programs primarily benefit patients whose insurance covers the brand at a higher copay tier. Generic zolpidem manufacturers do not typically run patient savings programs because the cash price is already low.
90-day fills. Some Maine pharmacies and insurance plans offer 90-day supplies at a reduced per-unit cost. A 90-day supply of generic zolpidem might cost $30 to $35, compared to $45 if filled monthly three times.
Maine Rx Plus. Maine operates the Maine Rx Plus program, a state-sponsored discount program for residents who lack prescription drug coverage or whose coverage has high out-of-pocket costs. Eligibility is based on income (up to 300% of the federal poverty level). The program negotiates rebates from manufacturers and passes savings to enrollees at the pharmacy counter [10].
Costco pharmacy. Maine residents do not need a Costco membership to use the Costco pharmacy. Costco's cash prices for generics are often among the lowest in the state, and their zolpidem pricing typically falls in the $4 to $8 range for a 30-day supply.
Clinical Context: When Zolpidem Is Prescribed
Zolpidem is FDA-approved for the short-term treatment of insomnia characterized by difficulty with sleep initiation [1]. The drug binds selectively to the alpha-1 subunit of the GABA-A receptor, producing sedation without the broader anxiolytic and muscle-relaxant effects of older benzodiazepines [2].
The AASM's 2017 clinical practice guideline recommends that clinicians use CBT-I as first-line treatment for chronic insomnia in adults [3]. Pharmacotherapy, including zolpidem, is positioned as second-line or as an adjunct when CBT-I alone is insufficient. The guideline assigns zolpidem a "weak" recommendation based on moderate-quality evidence, noting benefits in sleep latency reduction and sleep quality improvement.
Short-term prescribing is standard. The Ambien label specifies that treatment should be re-evaluated if insomnia does not remit after 7 to 10 days [1]. Long-term use beyond 4 to 5 weeks lacks strong evidence of continued efficacy and raises concerns about dependence and complex sleep behaviors, including sleepwalking, sleep-driving, and sleep-eating. In 2019, the FDA added a boxed warning to all sedative-hypnotics, including zolpidem, regarding the risk of complex sleep behaviors that can result in serious injury or death [11].
Dose matters. Women should start at 5 mg and men at 5 mg or 10 mg. The extended-release formulation starts at 6.25 mg for women and 6.25 mg or 12.5 mg for men. Patients over age 65 should use the lowest available dose regardless of sex, as hepatic clearance declines with age. A 2014 pharmacoepidemiologic study found that emergency department visits related to zolpidem adverse effects disproportionately involved women and adults over 65 [12].
Alternatives to Zolpidem Available in Maine
Patients who cannot access zolpidem or prefer a different medication have several options available at Maine pharmacies.
Eszopiclone (Lunesta). Generic eszopiclone costs roughly $15 to $30 per month in Maine. It has a longer half-life than zolpidem and may help with both sleep onset and sleep maintenance. The AASM guideline gives it a "weak" recommendation [3].
Suvorexant (Belsomra) and lemborexant (Dayvigo). These dual orexin receptor antagonists (DORAs) represent a newer drug class. Brand-name pricing is significantly higher ($300 to $400 per month without insurance). DORAs may be appropriate for patients with both sleep-onset and sleep-maintenance difficulty. The AASM guideline recommends suvorexant with a "conditional" suggestion [3].
Doxepin (Silenor). Low-dose doxepin (3 mg or 6 mg) is FDA-approved for insomnia characterized by difficulty with sleep maintenance. Generic doxepin is inexpensive, often under $15 per month.
Over-the-counter options. Diphenhydramine and doxylamine are available without a prescription. The AASM recommends against their use for chronic insomnia due to limited efficacy data and anticholinergic side effects [3]. Melatonin, while widely available, has mixed evidence for adult insomnia outside of circadian rhythm disorders.
Dr. Andrew Krystal, a sleep researcher at UCSF whose work has shaped zolpidem dosing guidelines, noted in a 2010 publication: "The clinical utility of zolpidem extended-release lies primarily in its ability to maintain effective plasma concentrations through the second half of the night" [2]. This distinction matters for patients choosing between formulations.
The American College of Physicians (ACP) released guidance stating: "Clinicians should use cognitive behavioral therapy for insomnia as initial treatment for chronic insomnia disorder in adults" [13]. This recommendation, graded as "strong," underscores that medication choice, whether zolpidem or an alternative, should follow a structured behavioral intervention.
Frequently asked questions
›How much does Ambien cost in Maine?
›Does Maine Medicaid cover Ambien?
›Is compounded zolpidem legal in Maine?
›Can I get Ambien via telehealth in Maine?
›Which insurance plans cover Ambien in Maine?
›What's the cheapest way to get Ambien in Maine?
›Are there Maine Ambien discount programs?
›How does the Sanofi savings card work in Maine?
›What dose of zolpidem should I take?
›Is zolpidem a controlled substance in Maine?
›Can I get a 90-day supply of zolpidem in Maine?
›Does zolpidem have a boxed warning?
References
- FDA. Ambien (zolpidem tartrate) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/019908s027lbl.pdf
- Krystal AD, Erman M, Zammit GK, et al. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep. 2008;31(1):79-90. https://pubmed.ncbi.nlm.nih.gov/20617910/
- Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307-349. https://pubmed.ncbi.nlm.nih.gov/27998379/
- Centers for Medicare and Medicaid Services. Medicare Part D formulary finder. https://www.cms.gov/
- Centers for Medicare and Medicaid Services. Inflation Reduction Act and Medicare Part D. https://www.cms.gov/
- FDA Drug Safety Communication. Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem. January 2013. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-risk-next-morning-impairment-after-use-insomnia-drugs
- FDA. Drug Quality and Security Act (DQSA). https://www.fda.gov/drugs/pharmaceutical-quality-resources/drug-quality-and-security-act
- Maine Legislature. Title 24-A, Section 4316: Coverage for health care services delivered through telehealth. https://www.mainelegislature.org/
- DEA. Telemedicine prescribing of controlled substances. Final rule 2025. https://www.deadiversion.usdoj.gov/
- Maine Department of Health and Human Services. Maine Rx Plus Program. https://www.maine.gov/dhhs/
- FDA Drug Safety Communication. FDA adds boxed warning for risk of serious injuries caused by sleepwalking with certain prescription insomnia medicines. April 2019. https://www.fda.gov/drugs/drug-safety-and-availability/fda-adds-boxed-warning-risk-serious-injuries-caused-sleepwalking-certain-prescription-insomnia
- Hampton LM, Daubresse M, Chang HY, et al. Emergency department visits by adults for psychiatric medication adverse events. JAMA Psychiatry. 2014;71(9):1006-1014. https://pubmed.ncbi.nlm.nih.gov/25006837/
- Qaseem A, Kansagara D, Forciea MA, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125-133. https://pubmed.ncbi.nlm.nih.gov/27136449/